by DONNA MARIA COLES JOHNSON on November 2, 2009
I am pleased to announce that, on December 3 and 4, I’m leading another delegation to the US Food & Drug Administration (FDA). The purpose of my visits is to share small business perspectives on pending cosmetics legislation, and also on current rules, regulations and current events affecting the cosmetics industry.
This is my second trip, and it comes after months of new developments where legal issues affecting small and independent business owners are concerned. This time, I will be accompanied by longtime IBN member Lela Barker of Bella Lucce (who came on my last trip) and Leigh O’Donnell, president of the Handcrafted Soapmakers Guild. Continue Reading…
by DONNA MARIA COLES JOHNSON on November 2, 2009
[An article about this bill was originally published in April 2009 at my old FDA Globalization Act blog. Due to a technical glitch, the article did not transfer here. This is what I recall of that post.]
In April 2009, Senator Kirsten Gillibrand (D-NY) introduced the “Safe Baby Products Act of 2009 (PDF) requiring that the Food & Drug Administration (FDA) test cosmetics and personal care products that are likely contaminated with impurities or contaminants, including several ingredients specified in the bill.*
The bill is aimed specifically at products intended for children aged 7 and under such as baby shampoo, baby bath, lipstick, nail polish, lotion, cream, sunscreen, liquid soa, and baby wipes). The bill requires Congress to submit the test results to Congress and to make them public. Continue Reading…
